Organizing Committee

iWomenHealth_Organizing_Michael_Retsky

Michael Retsky

University College 
London

(For i-WomenHealth 2022)

Michael Retsky received PhD in physics from University of Chicago and worked in experimental physics at Zenith Electronics and Hewlett-Packard. After making a career change into cancer research 30 years ago, he was Prof of Biology at University of Colorado and visiting Prof at University of Texas. He is presently a Associate Professor at University College, London. Michael’s current area of interest is to study cancer using computer simulation. Retsky is Editor of a Springer-Nature book on the breast cancer project published July 2017.He was the first person to use what is now called metronomic chemotherapy for stage IIIc colon cancer in 1995-1997. He is a founder and for 10 years was on the Board of Directors of the Colon Cancer Alliance. He has published more than 100 papers in physics and oncology.

iWomenHealth_Organizing_Alexander _M. Seifalian

Alexander M. Seifalian

Nanotechnology & Regenerative Medicine Commercialisation Centre (NanoRegMed Ltd, Nanoloom Ltd) & ConViCure Inc, USA

London BioScience Innovation Centre, UK

(For i-WomenHealth 2022)

 

Alexander Seifalian, professor of nanotechnology and regenerative medicine, worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at the cause of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and international patents. Alexander's career spans decades in the fields of nanotechnology and regenrative medicine. His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, and the development of organs using tissue engineering and nanoparticles for detection and treatment of cancer. He is currently CEO of NanoRegMed Ltd, working on the commercialization of his research. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit and vascular bypass graft using nanocomposite materials,bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN and many more.

iWomenHealth_Organizing_Namsun_Paik

Namsun Paik

Director

Ewha Womans University Cancer Center Hospital for Women

South Korea

(For i-WomenHealth 2022)

Nam-Sun Paik had completed his graduation from School of Medicine, Seoul National University in 1973 and is currently the Director of Ewha Womens University Cancer Center for Women, Seoul Korea from 2011. He served as President of Konkuk University Medical Center from 2009 to 2011, President of Asian Breast Cancer Society (2006-2008) and was selected as one of the top 100 Health Professionals as of Breast and Stomach Surgical Oncologist, International Biographical Center of Cambridge, England in 2006. He also served as President of Korean Breast Cancer Society (2001-2003), President of the 3rd Asian Breast Cancer Society Congress 2000-2001 and was selected as one of the top 100 Health Professional as of Breast and Stomach Surgical Oncologist. Cambridge, England in 2006 and as a Man of the Year, International Biographical Center of Cambridge, England in 2001.

Jens Hahne _International Women Health and Breast Cancer Conference

Jens Hahne

Higher Scientific Officer

The Institute of Cancer Research

UK

(i-Women Health 2019)

J C Hahne received his PhD in Biochemistry from the Albert-Ludwigs-University Freiburg i.Br. (Germany). During his  PhD work, he was trained in virology, cell- and molecular-biology.During several Postdoc positions in Department of Molecular Pathology at the University of Bonn (Germany), Charite Berlin (Germany), and Department of Gynaecology and Obstetrics at the University of Wuerzburg (Germany), he received a broad training and knowledge in molecular pathology and cancer research. At the moment, he is working in the Department of Molecular Pathology at the ICR (London, UK). He has published more than 65 papers in reputed journals and has been serving as an Editorial Board Member of repute.

Michael Friedrich_International Women Health and Breast Cancer Conference

Michael Friedrich

HELIOS Hospital

Germany
(i-Women Health 2019)

 

Michael Friedrich completed PhD from Freiburg University and Postdoctoral studies from Stanford University School of Medicine. He is the Director of the Department of Obstetrics and Gynecology of the HELIOS Hospital Krefeld, teaching hospital of the University of Aachen. He has published more than 100 papers in reputed journals and has been serving as an Editorial Board Member of many reputed journals.

Magnus S Magnusson_International Women Health and Breast Cancer Conference

Magnus S Magnusson

University of Iceland

Iceland

(i-Women Health 2019)

Magnus S Magnusson is a Professor, completed his PhD in 1983 at University of Copenhagen. Founder and director of the Human Behavior Laboratory of the University of Iceland. He has presented various papers and invited for talks at various conferences in Europe, USA and Japan.

Shawky Z A Badawy_International Women Health and Breast Cancer Conference

Shawky Z A Badawy

Director

Upstate Medical University

USA

(i-Women Health 2019)

Shawky Z A Badawy is Division Chief of Reproductive Endocrinology and Infertility at Upstate Medical University. He is Board Certified in Obstetrics and Gynecology and Subspecialty Certified in Reproductive Endocrinology and Infertility; and is a member of  American Society for Reproductive Medicine (ASRM), Society for Reproductive Endocrinology and Infertility (SREI) and North American Menopause Society (NAMS). His clinical interests include endometriosis, infertility management, menstrual dysfunction, laparoscopic and hysteroscopic surgery, and microsurgery.